InvestorsHub Logo
icon url

jimsgtx

09/30/14 7:02 AM

#192146 RE: BKT #192145

Olivero AG; Genentech PI3K Research Team. Discovery of GDC-0032, a beta-sparing PI3K inhibitor active against PIK3CA mutant tumors. Presented at: AACR Annual Meeting; April 6-10, 2013; Washington, DC.
icon url

microbe_man

09/30/14 7:14 AM

#192149 RE: BKT #192145

This has nothing to do with PS targeting. It is amazing how some investors on this board take any information and somehow relate it to Peregrine.
icon url

hutschi

09/30/14 8:03 AM

#192156 RE: BKT #192145

Phosphatidylinositol

http://en.wikipedia.org/wiki/Phosphatidylinositol

German Wiki:
http://de.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphat

Ther you find: Phospholipiden (Link in the first line)

http://de.wikipedia.org/wiki/Phospholipide

and there you find OUR PS!!!